Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice

on behalf of the AST ID Community of Practice

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice address the prevention and management of Clostridium difficile infection in solid organ transplant (SOT) recipients. Clostridioides (formerly Clostridium) difficile infection (CDI) is among the most common hospital acquired infections. In SOT recipients, the incidence of CDI varies by type and number or organs transplanted. While a meta-analysis of published literature found the prevalence of postoperative CDI in the general surgical population to be approximately 0.51%, the prevalence of CDI that is seen in the solid organ transplant population ranges from a low of 3.2% in the pancreatic transplant population to 12.7% in those receiving multiple organ transplants. There are no randomized, controlled trials evaluating the management of CDI in the SOT population. Herein is a review and summary of the currently available literature that has been synthesized into updated treatment guidelines for the management of CDI in the SOT population.

Original languageEnglish
Article numbere13564
JournalClinical Transplantation
Volume33
Issue number9
DOIs
StatePublished - Sep 1 2019

Keywords

  • Clostridium difficile
  • antibiotic-associated diarrhea
  • nosocomial infection
  • pseudomembranous colitis
  • solid organ transplant

Fingerprint

Dive into the research topics of 'Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice'. Together they form a unique fingerprint.

Cite this